Summary TogglePLx Pharma Inc. Presents Original Abstract and Simultaneous Publication of its Novel, Liquid-Filled Capsule Aspirin Formulation at the 2020 International Stroke Conference
(WorldNews Health)

PLx Pharma Inc. Presents Original Abstract and Simultaneous Publication of its Novel, Liquid-Filled Capsule Aspirin Formulation at the 2020 International Stroke Conference February 21, 2020 VAZALORE`s novel mechanism of action ensures consistent aspirin bioavailability with administration in both fasting and fed conditions SPARTA, N.J., Feb. 21, 2020 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) ("PLx" or the "Company"), a late-stage specialty pharmaceutical company focused on developing more effective and safer products with its patent-protected PLxGuardTM delivery system, announced today the presentation of an original poster on VAZALORETM 325 mg at the 2020...